Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of single-dose metformin extended-release tablets (III) vs divided-dose immediate-release metformin
ChiCTR2400091642Phase 4Completed
- Sponsor
- Peking University First Hospital Department of Endocrinology
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Peking University First Hospital Department of Endocrinology. Primary endpoints: AUC0-24, Tmax and 1 more. Started Oct 2024; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2400091642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091642.